D-0399-2021 Class I Terminated

Recalled by Acella Pharmaceuticals, LLC — Alpharetta, GA

FDA drug recall D-0399-2021 was initiated by Acella Pharmaceuticals, LLC on Apr 29, 2021 and is designated Class I. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 13, 2024). Affected quantity: a) 69,289 bottles; b) 9,076 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 2, 2021
Initiation Date
Apr 29, 2021
Termination Date
Mar 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 69,289 bottles; b) 9,076 bottles

Product description

NP Thyroid 120 Thyroid Tablets, USP 2 grain (120 mg), packaged in a) 100-count bottles (NDC 42192-328-01) and b) 7-count bottles (NDC 42192-328-07) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the United States including Puerto Rico

Code information

Lot #: a) M328H19-2B, M328J19-11, M328J19-2A, M328J19-3A, M328J19-4A M328J19-5A, M328J19-6A, M328J19-7A, Exp. 08/31/2021, M328K19-2, M328K19-4A, Exp. 09/30/2021; b) M328J19-9B Exp. 08/31/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0399-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0399-2021. Report a data issue: hello@regdatalab.com.